References
1. Stern JH, Rutkowski JM, Scherer PE.
Adiponectin, leptin, and fatty acids in the maintenance of metabolic
homeostasis through adipose tissue crosstalk. Cell metabolism.2016;23(5):770-784.
2. Abou-Samra M, Selvais CM, Dubuisson
N, Brichard SM. Adiponectin and Its Mimics on Skeletal Muscle: Insulin
Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills… or
Everything Together? International Journal of Molecular Sciences.2020;21(7):2620.
3. Achari AE, Jain SK. Adiponectin, a
therapeutic target for obesity, diabetes, and endothelial dysfunction.International journal of molecular sciences. 2017;18(6):1321.
4. Ferrarezi DA, Cheurfa N, Reis AF,
Fumeron F, Velho G. Adiponectin gene and cardiovascular risk in type 2
diabetic patients: a review of evidences. Arquivos Brasileiros de
Endocrinologia & Metabologia. 2007;51(2):153-159.
5. Travier N, Buckland G, Vendrell JJ,
et al. Changes in metabolic risk, insulin resistance, leptin and
adiponectin following a lifestyle intervention in overweight and obese
breast cancer survivors. European journal of cancer care.2018;27(4):e12861.
6. Laughlin GA, Barrett-Connor E, May
S, Langenberg C. Association of adiponectin with coronary heart disease
and mortality: the Rancho Bernardo study. American journal of
epidemiology. 2006;165(2):164-174.
7. La Cava A. Leptin in inflammation
and autoimmunity. Cytokine. 2017;98:51-58.
8. Denroche HC, Huynh FK, Kieffer TJ.
The role of leptin in glucose homeostasis. Journal of diabetes
investigation. 2012;3(2):115-129.
9. Ahima RS. Revisiting leptin’s role
in obesity and weight loss. The Journal of clinical
investigation. 2008;118(7):2380-2383.
10. Jheng HF, Hirotsuka M, Goto T,
Shibata M, Matsumura Y, Kawada T. Dietary low‐fat soy milk powder
retards diabetic nephropathy progression via inhibition of renal
fibrosis and renal inflammation. Molecular nutrition & food
research. 2017;61(3):1600461.
11. González-Montoya M,
Hernández-Ledesma B, Silván JM, Mora-Escobedo R, Martínez-Villaluenga C.
Peptides derived from in vitro gastrointestinal digestion of germinated
soybean proteins inhibit human colon cancer cells proliferation and
inflammation. Food chemistry. 2018;242:75-82.
12. Peng Y, Shi Y, Zhang H, Mine Y,
Tsao R. Anti-inflammatory and anti-oxidative activities of daidzein and
its sulfonic acid ester derivatives. Journal of Functional Foods.2017;35:635-640.
13. Meng H, Fu G, Shen J, et al.
Ameliorative effect of daidzein on cisplatin-induced nephrotoxicity in
mice via modulation of inflammation, oxidative stress, and cell death.Oxidative medicine and cellular longevity. 2017;2017.
14. Holmdahl R, Sareila O, Olsson LM,
Bäckdahl L, Wing K. Ncf1 polymorphism reveals oxidative regulation of
autoimmune chronic inflammation. Immunological reviews.2016;269(1):228-247.
15. Charles C, Yuskavage J, Carlson
O, et al. Effects of high-dose isoflavones on metabolic and inflammatory
markers in healthy postmenopausal women. Menopause (New York,
NY). 2009;16(2):395.
16. Llaneza P, González C,
Fernandez-Iñarrea J, et al. Soy isoflavones, diet and physical exercise
modify serum cytokines in healthy obese postmenopausal women.Phytomedicine. 2011;18(4):245-250.
17. Ma L, Grann K, Li M, Jiang Z. A
pilot study to evaluate the effect of soy isolate protein on the serum
lipid profile and other potential cardiovascular risk markers in
moderately hypercholesterolemic Chinese adults. Ecology of food
and nutrition. 2011;50(6):473-485.
18. Zemel MB, Sun X, Sobhani T,
Wilson B. Effects of dairy compared with soy on oxidative and
inflammatory stress in overweight and obese subjects. The American
journal of clinical nutrition. 2010;91(1):16-22.
19. Vargas ML, Almario RU, Buchan W,
Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus
essential omega-3 polyunsaturated fatty acids in polycystic ovary
syndrome. Metabolism. 2011;60(12):1711-1718.
20. Maskarinec G, Steude JS, Franke
AA, Cooney RV. Inflammatory markers in a 2-year soy intervention among
premenopausal women. Journal of Inflammation. 2009;6(1):9.
21. Napora JK, Short RG, Muller DC,
et al. High‐dose isoflavones do not improve metabolic and inflammatory
parameters in androgen‐deprived men with prostate cancer. Journal
of andrology. 2011;32(1):40-48.
22. Takahira M, Noda K, Fukushima M,
et al. Randomized, double-blind, controlled, comparative trial of
formula food containing soy protein vs. milk protein in visceral fat
obesity. Circulation Journal. 2011;75(9):2235-2243.
23. Riesco E, Choquette S, Audet M,
Lebon J, Tessier D, Dionne IJ. Effect of exercise training combined with
phytoestrogens on adipokines and C-reactive protein in postmenopausal
women: a randomized trial. Metabolism. 2012;61(2):273-280.
24. Rebholz C, Reynolds K, Wofford M,
et al. Effect of soybean protein on novel cardiovascular disease risk
factors: a randomized controlled trial. European journal of
clinical nutrition. 2013;67(1):58-63.
25. Nadadur M, Stanczyk FZ, Tseng
C-C, Kim L, Wu AH. The effect of reduced dietary fat and soy
supplementation on circulating adipocytokines in postmenopausal women: a
randomized controlled 2-month trial. Nutrition and cancer.2016;68(4):554-559.
26. Deibert P, Lazaro A, Schaffner D,
et al. Comprehensive lifestyle intervention vs soy protein-based meal
regimen in non-alcoholic steatohepatitis. World Journal of
Gastroenterology. 2019;25(9):1116.
27. Llanos AA, Peng J, Pennell ML, et
al. Effects of tomato and soy on serum adipokine concentrations in
postmenopausal women at increased breast cancer risk: a cross-over
dietary intervention trial. The Journal of Clinical Endocrinology
& Metabolism. 2014;99(2):625-632.
28. Liberati A, Altman DG, Tetzlaff
J, et al. The PRISMA statement for reporting systematic reviews and
meta-analyses of studies that evaluate health care interventions:
explanation and elaboration. Annals of internal medicine.2009;151(4):W-65-W-94.
29. Fedorov S. GetData Graph
Digitizer version 2.24. Available at www getdata-graph-digitizer
com. 2002;541:542.
30. Higgins JP, Altman DG, Gøtzsche
PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias
in randomised trials. Bmj. 2011;343:d5928.
31. Liberati A, Altman DG, Tetzlaff
J, et al. The PRISMA statement for reporting systematic reviews and
meta-analyses of studies that evaluate health care interventions:
explanation and elaboration. PLoS medicine. 2009;6(7):e1000100.
32. Borenstein M, Hedges LV, Higgins
JP, Rothstein HR. Introduction to meta-analysis. John Wiley &
Sons; 2011.
33. Tobias A. Assessing the influence
of a single study in the meta-anyalysis estimate. Stata Technical
Bulletin. 1999;8(47).
34. Christie DR, Grant J, Darnell BE,
Chapman VR, Gastaldelli A, Sites CK. Metabolic effects of soy
supplementation in postmenopausal Caucasian and African American women:
a randomized, placebo-controlled trial. American journal of
obstetrics and gynecology. 2010;203(2):153. e151-153. e159.
35. König D, Deibert P, Frey I,
Landmann U, Berg A. Effect of meal replacement on metabolic risk factors
in overweight and obese subjects. Annals of Nutrition and
Metabolism. 2008;52(1):74-78.
36. Wu AH, Stanczyk FZ, Martinez C,
et al. A controlled 2-mo dietary fat reduction and soy food
supplementation study in postmenopausal women. The American
journal of clinical nutrition. 2005;81(5):1133-1141.
37. Llaneza P, Gonzalez C,
Fernández-Iñarrea J, Alonso A, Diaz F, Pérez-López FR. Soy isoflavones
improve insulin sensitivity without changing serum leptin among
postmenopausal women. Climacteric. 2012;15(6):611-620.
38. Lozovoy MAB, Bahls LD, Morimoto
HK, Matsuo T, Dichi I. Blood pressure decrease with ingestion of a soya
product (kinako) or fish oil in women with the metabolic syndrome: role
of adiponectin and nitric oxide. British journal of nutrition.2012;108(8):1435-1442.
39. Deibert P, Solleder F, König D,
et al. Soy protein based supplementation supports metabolic effects of
resistance training in previously untrained middle aged males. The
Aging Male. 2011;14(4):273-279.
40. Rebholz CM, Friedman EE, Powers
LJ, Arroyave WD, He J, Kelly TN. Dietary protein intake and blood
pressure: a meta-analysis of randomized controlled trials.American journal of epidemiology. 2012;176(suppl_7):S27-S43.
41. Reynolds K, Chin A, Lees KA,
Nguyen A, Bujnowski D, He J. A meta-analysis of the effect of soy
protein supplementation on serum lipids. The American journal of
cardiology. 2006;98(5):633-640.
42. Yun JE, Sull JW, Lee HY, et al.
Serum adiponectin as a useful marker for metabolic syndrome in type 2
diabetic patients. Diabetes/metabolism research and reviews.2009;25(3):259-265.
43. Imerbtham T, Thitiwuthikiat P,
Jongjitwimol J, Nuamchit T, Yingchoncharoen T, Siriwittayawan D. Leptin
Levels are Associated with Subclinical Cardiac Dysfunction in Obese
Adolescents. Diabetes, Metabolic Syndrome and Obesity: Targets and
Therapy. 2020;13:925.
44. Ahima RS, Flier JS. Adipose
tissue as an endocrine organ. Trends in Endocrinology &
Metabolism. 2000;11(8):327-332.
45. Triantafyllou GA, Paschou SA,
Mantzoros CS. Leptin and hormones: energy homeostasis.Endocrinology and Metabolism Clinics. 2016;45(3):633-645.
46. Perez-Suarez I, Ponce-González
JG, de La Calle-Herrero J, et al. Severe energy deficit upregulates
leptin receptors, leptin signaling, and PTP1B in human skeletal muscle.Journal of Applied Physiology. 2017;123(5):1276-1287.
47. Cnop M, Havel PJ, Utzschneider K,
et al. Relationship of adiponectin to body fat distribution, insulin
sensitivity and plasma lipoproteins: evidence for independent roles of
age and sex. Diabetologia. 2003;46(4):459-469.
48. Nishizawa H, Shimomura I, Kishida
K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing
adipocyte-derived protein. Diabetes. 2002;51(9):2734-2741.
49. Haun CT, Mobley CB, Vann CG, et
al. Soy protein supplementation is not androgenic or estrogenic in
college-aged men when combined with resistance exercise training.Scientific reports. 2018;8(1):1-13.
50. Gavrila A, Chan JL, Yiannakouris
N, et al. Serum adiponectin levels are inversely associated with overall
and central fat distribution but are not directly regulated by acute
fasting or leptin administration in humans: cross-sectional and
interventional studies. The Journal of Clinical Endocrinology &
Metabolism. 2003;88(10):4823-4831.
51. Sieminska L, Wojciechowska C,
Niedziolka D, et al. Effect of postmenopause and hormone replacement
therapy on serum adiponectin levels. Metabolism.2005;54(12):1610-1614.
52. Casabiell X, Pineiro V, Peino R,
et al. Gender differences in both spontaneous and stimulated leptin
secretion by human omental adipose tissue in vitro: dexamethasone and
estradiol stimulate leptin release in women, but not in men. The
Journal of clinical endocrinology and metabolism. 1998;83(6):2149-2155.
53. Zhang R, Liao E, Wu X, et al.
Concentration of serum leptin and age in Chinese women and comparison
with other races. Zhong nan da xue xue bao Yi xue ban= Journal of
Central South University Medical sciences. 2009;34(11):1136-1141.
54. Yanagisawa M, Sugiya M, Iijima H,
Nakagome I, Hirono S, Tsuda T. Genistein and daidzein, typical soy
isoflavones, inhibit TNF‐α‐mediated downregulation of adiponectin
expression via different mechanisms in 3 T 3‐L 1 adipocytes.Molecular nutrition & food research. 2012;56(12):1783-1793.
55. Zhang H-M, Chen S-W, Zhang L-S,
Feng X-F. The effects of soy isoflavone on insulin sensitivity and
adipocytokines in insulin resistant rats administered with high-fat
diet. Natural product research. 2008;22(18):1637-1649.